Literature DB >> 496460

Racial differences in espundia.

B C Walton, L Valverde.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 496460     DOI： 10.1080/00034983.1979.11687222

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  9 in total

1.  Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation.

Authors:  M S Giannini
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Characterization of Leishmania (Leishmania) waltoni n.sp. (Kinetoplastida: Trypanosomatidae), the Parasite Responsible for Diffuse Cutaneous Leishmaniasis in the Dominican Republic.

Authors:  Jeffrey Shaw; Francine Pratlong; Lucile Floeter-Winter; Edna Ishikawa; Fouad El Baidouri; Christophe Ravel; Jean-Pierre Dedet
Journal:  Am J Trop Med Hyg       Date:  2015-07-06       Impact factor: 2.345

3.  T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species.

Authors:  Yira Rosalba Díaz; Ricardo Rojas; Liliana Valderrama; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

4.  Intralesional isotype profiles in human localized cutaneous leishmaniasis lesions.

Authors:  R Aragort De Rossell; M Calcagno; O Rossell; Z Maizo De Segnini; A M Rodríguez
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

5.  Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.

Authors:  A Alcaïs; L Abel; C David; M E Torrez; P Flandre; J P Dedet
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

Review 6.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  The site of Leishmania major infection determines disease severity and immune responses.

Authors:  Tracey M Baldwin; Colleen Elso; Joan Curtis; Lynn Buckingham; Emanuela Handman
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Human genetic susceptibility and infection with Leishmania peruviana.

Authors:  M A Shaw; C R Davies; E A Llanos-Cuentas; A Collins
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

9.  Vaccine Development Against Leishmania donovani.

Authors:  Amrita Das; Nahid Ali
Journal:  Front Immunol       Date:  2012-05-15       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.